Beta Thalassemia Major: Clinical Trials

4 trials for Beta Thalassemia Major, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 unknown, 1 completed, 1 terminated. 4 Phase 2, 1 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 24Unknown 2, Completed 1, Terminated 1
Phase 11Unknown 1
Phase 31Unknown 1

Follow Beta Thalassemia Major: new trials by email Literature Review of Beta Thalassemia Major trials Research Report on Beta Thalassemia Major

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase 2a Pilot Study of NBMI Treatment in Patients With Beta Thalassemia Major, Requiring Iron Chelation
Emeramide - Beta Thalassemia Major
Phase 2CompletedEmeraMed132019-11-212021-08-26
Gene Therapy for Beta-Thalassemia Major Using Autologous Hematopoietic Stem Cell Genetically Modified
Autologous CD34+ cells genetically modified - Beta Thalassemia Major
Phase 1 / Phase 2UnknownNanfang Hospital, Southern Medical University102017-09-152017-09-08
An Algorithm to Start Iron Chelation in Minimally Transfused Young Beta-thalassemia Major Patients
Deferiprone - Beta Thalassemia Major
Phase 2 / Phase 3UnknownAin Shams University642014-07-012015-01-14
Study to Determine the Safety and Tolerability of Sotatercept (ACE-011) in Adults With Beta( β)- Thalassemia.
SOTATERCEPT (ACE-011) - Beta Thalassemia Major, Beta Thalassemia Intermedia
Phase 2TerminatedCelgene462012-10-102023-06-18

Narrower conditions

beta-Thalassemia (4)

Broader conditions

Anemia (4)  ·  Anemia, Hemolytic (4)  ·  Anemia, Hemolytic, Congenital (4)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (4)  ·  Genetic Diseases, Inborn (4)  ·  Hematologic Diseases (4)  ·  Hemic and Lymphatic Diseases (4)  ·  Hemoglobinopathies (4)  ·  Thalassemia (4)

Interventions

ACE-011 (1)  ·  Deferiprone (1)  ·  N,N'-Bis(2-mercaptoethyl)isophthalamide (1)

Sponsors

Ain Shams University (1)  ·  Celgene (1)  ·  EmeraMed (1)  ·  Nanfang Hospital, Southern Medical University (1)

Countries

Albania (1)  ·  China (1)  ·  Egypt (1)  ·  France (1)  ·  Greece (1)  ·  Italy (1)  ·  United Kingdom (1)

Top investigators

Mohsen S Elalfy, professour (1)

Results publications

PMID 29119631, PMID 37975597